Reversible left ventricular hypertrophy after tako-tsubo-like cardiomyopathy

Acta Cardiol. 2005 Feb;60(1):77-9. doi: 10.2143/AC.60.1.2005056.

Abstract

Tako-tsubo-like cardiomyopathy is a newly-recognized enigmatic disease characterized by transient left ventricular dysfunction of a broad area of the apex with a hyperkinetic area around the cardiac base. There is ST-segment elevation with no coronary stenosis. The exact mechanism for this entity remains unknown. Here, we report a case of tako-tsubo-like cardiomyopathy that showed a marked left ventricular hypertrophy (LVH) when the wall motion returned to normal. LVH was normalized at 10 months. The cause of LVH remains unknown.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Aspirin / therapeutic use
  • Benzimidazoles / therapeutic use
  • Biphenyl Compounds
  • Cardiomyopathy, Dilated / complications
  • Cardiomyopathy, Dilated / diagnosis*
  • Chest Pain / diagnosis
  • Chest Pain / etiology
  • Drug Therapy, Combination
  • Electrocardiography
  • Female
  • Follow-Up Studies
  • Humans
  • Hypertrophy, Left Ventricular / complications
  • Hypertrophy, Left Ventricular / diagnosis*
  • Hypertrophy, Left Ventricular / drug therapy
  • Magnetic Resonance Imaging
  • Myocardial Ischemia / complications
  • Myocardial Ischemia / diagnosis*
  • Myocardial Ischemia / drug therapy
  • Nifedipine / therapeutic use
  • Risk Assessment
  • Severity of Illness Index
  • Tetrazoles / therapeutic use
  • Ventricular Dysfunction, Left / complications
  • Ventricular Dysfunction, Left / diagnosis*
  • Ventricular Dysfunction, Left / drug therapy

Substances

  • Benzimidazoles
  • Biphenyl Compounds
  • Tetrazoles
  • Nifedipine
  • Aspirin
  • candesartan